Skip to main content
. 2015 Dec 29;5(2):285–293. doi: 10.1002/cam4.596

Table 2.

Overall immunogenicity to trivalent inactivated influenza vaccine in immunocompromised children receiving treatment for cancer

Vaccine strain GMFI (95% CI) P value Seroprotection % (95% CI) P value Seroconversion % (95% CI) P value
H3N2 (A) 4.56 (3.19–6.52) <0.01 55 (45.2–64.8) >0.99 43 (33.3–52.7) 0.27
H1N1 (A) 4.44 (3.19–6.19) <0.01 61 (51.4–70.6) 0.98 43 (33.3–52.7) 0.27
B 3.07 (2.17–4.36) 0.12 41 (31.4–50.6) >0.99 33 (23.8–42.2) 0.92

GMFI, geometric mean fold increase.